The Asia Pacific Infant Incubator Market would witness market growth of 7.7% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 69.5 thousand units, showcasing a growth of 7.7% (2019-2022).
The escalating number of preterm births is a significant driver for the infant incubator market. Factors such as maternal age, multiple pregnancies, and lifestyle-related issues contribute to the rise in premature births, necessitating the use of incubators to ensure the well-being of these vulnerable infants. Greater awareness about the importance of neonatal care and improved healthcare infrastructure, particularly in developing regions, have contributed to the increased adoption of infant incubators. Governments and healthcare organizations are investing in upgrading facilities to provide better neonatal care, boosting the market.
Advances in neonatal medicine and a deeper understanding of the unique healthcare needs of premature infants have driven the development of sophisticated incubators with features tailored to address specific challenges associated with neonatal care. This continuous innovation is fostering the growth of the market. The rise in disposable income and increased healthcare expenditure, particularly in emerging economies, have expanded the accessibility of advanced medical equipment, including infant incubators. This economic factor contributes to the market's growth by enhancing the purchasing power of healthcare facilities.
According to the National Library of Medicine, in 2023, the prevalence of low birth weight (LBW) and Preterm birth (PTB) in India was 18% and 13%, respectively. India faces a high burden of LBW and PTB cases, with a considerable percentage of newborns being born underweight or prematurely. This prevalence underscores the need for neonatal care interventions, including infant incubators, to address the unique challenges these infants face. The Indian government has been actively involved in initiatives to improve maternal and child health, recognizing the challenges associated with LBW and PTB. The aforementioned factors will drive the market growth in this region.
The China market dominated the Asia Pacific Infant Incubator Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $61,517.6 Thousands by 2030. The Japan market is showcasing a CAGR of 6.9% during (2023 - 2030). Additionally, The India market would register a CAGR of 8.3% during (2023 - 2030).
Based on Product, the market is segmented into Normal Incubator, Transport Incubator, and Hybrid Incubator. Based on Application, the market is segmented into Neonatal hypothermia & low birth weight, Jaundice, and Others. Based on End User, the market is segmented into Neonatal & Pediatric Hospitals, Maternity Hospitals, and Hospitals. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Global Infant Incubator Market is Predict to reach $944.9 Million by 2030, at a CAGR of 6.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Natus Medical Incorporated (Archimed SAS), Atom Medical Corporation, Phoenix Medical Systems Pvt. Ltd., Dragerwerk AG & Co. KGaA, Inspiration Healthcare Group PLC, Medicor Elektronika Zrt., Fanem Ltda., Koninklijke Philips N.V., Médipréma Group.
By Product (Volume, Thousand Units, USD Million, 2019 to 2030)
By Application (Volume, Thousand Units, USD Million, 2019 to 2030)
By End User (Volume, Thousand Units, USD Million, 2019 to 2030)
By Country (Volume, Thousand Units, USD Million, 2019 to 2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
